BEGIN:VCALENDAR VERSION:2.0 PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90// CALSCALE:GREGORIAN UID:64633832-3163-4066-b736-353464313839 BEGIN:VEVENT UID:02b658094992fa3b9841af66029a517956ee3dda@swoogo.com DTSTAMP:20260407T210414Z DESCRIPTION:_PURCHASER-FOCUSED RX ADVISORY BOARD MEETING  _ \n  \n\nPROPOSE D PROJECT  \n\nThe National Alliance Medical Director Advisory Council has been asked for guidance developing and piloting a sustainable process for the following: \n\n * Review new drugs and therapies that are coming out i n the marketplace and provide education to employers about their impact an d how to best address the needs of their population. \n * Review recent IC ER report on comparative effectiveness research (CER) and help translate t he relevant findings for employers and other purchasers\, so they can best utilize these findings in their overall health care strategic planning. E xplore considerations for inclusion of additional employer-relevant metric s in value analysis.\n * Evaluate the potential development a value-based contract framework – that can inform and influence health plans/PBMs to mo re effectively align stakeholder interests. \n * Suggest a recommended pat h forward and a dissemination approach for purchasers.  \n\n \n\nDRAFT AGE NDA\n\n * Frame the environment and why we’re here – what our charge is for the day? \n\n * Discuss high-level strawman (level set) creating a value f ramework \n\n * What are the components of that framework – provide some ex ample reports\n * Define lessons learned  \n\n * Discuss issues and reacti ons – and determine what should we pay attention to\n\n * Group discussion - Highlight at least two case studies \n\n * Determine key learnings \n * H ow can this support the value framework?   \n\n * Determine key deliverabl es and next steps  \n\n  DTSTART:20191031T223000Z DTEND:20191101T200000Z LAST-MODIFIED:20260407T210414Z LOCATION:1015 18th St NW\, Washington\, DC 20036\, United States SEQUENCE:0 STATUS:CONFIRMED SUMMARY:Purchaser-Focused Rx Advisory Board Meeting TRANSP:OPAQUE X-ALT-DESC;FMTTYPE=text/html:
Purchaser-focused Rx Advis ory Board Meeting  
\n\n
 
\n\n
\n

PROPOSED PROJECT  

\n \n

The National Alliance Medical Director Advisory Council has been asked for guidance developing and piloting a sustainable process for the following: 

\n\n
  1. Review new drugs and therapies that are coming out in t he marketplace and provide education to employers about their impact and h ow to best address the needs of their population.
    2. \n
  2. Review recent ICER report on co mparative effectiveness research (CER) and help translate the relevant fin dings for employers and other purchasers\, so they can best utilize these findings in their overall health care strategic planning. Explore consider ations for inclusion of additional employer-relevant metrics in value anal ysis.
    3. \n
  3. Ev aluate the potential development a value-based contract framework – that c an inform and influence health plans/PBMs to more effectively align stakeh older interests.
    4. \n
  4. Suggest a recommended path forward and a dissemination approach for purchasers.  
    5. \n

 

\n\n

< span style='font-family:'Calibri Light'\, sans-serif\;'>DRAFT AGENDA

\n\n
  1. < span style='font-size:11pt\;'>Frame the en vironment and why we’re here – what our charge is for the day?
    2. \n
  2. Discuss high-level strawman (le vel set) creating a value framework\n
    1. What are the component s of that framework – provide some example reports\n
    2. Define lessons learned 
      3. \n
    3. \n
  3. Discuss issues and reactions – and determine what should we pay attention to
    4. \n
  4. Group discussion - Highlight at least two case studies \n
    1. Determine key learnings \n
    2. How can this support the value framework?  
      3. \n
    5. \n
  5. Determin e key deliverables and next steps 
    6. \n

 

\n
BEGIN:VALARM UID:63313865-3433-4633-b961-393833663431 ACTION:DISPLAY DESCRIPTION:_PURCHASER-FOCUSED RX ADVISORY BOARD MEETING  _ \n  \n\nPROPOSE D PROJECT  \n\nThe National Alliance Medical Director Advisory Council has been asked for guidance developing and piloting a sustainable process for the following: \n\n * Review new drugs and therapies that are coming out i n the marketplace and provide education to employers about their impact an d how to best address the needs of their population. \n * Review recent IC ER report on comparative effectiveness research (CER) and help translate t he relevant findings for employers and other purchasers\, so they can best utilize these findings in their overall health care strategic planning. E xplore considerations for inclusion of additional employer-relevant metric s in value analysis.\n * Evaluate the potential development a value-based contract framework – that can inform and influence health plans/PBMs to mo re effectively align stakeholder interests. \n * Suggest a recommended pat h forward and a dissemination approach for purchasers.  \n\n \n\nDRAFT AGE NDA\n\n * Frame the environment and why we’re here – what our charge is for the day? \n\n * Discuss high-level strawman (level set) creating a value f ramework \n\n * What are the components of that framework – provide some ex ample reports\n * Define lessons learned  \n\n * Discuss issues and reacti ons – and determine what should we pay attention to\n\n * Group discussion - Highlight at least two case studies \n\n * Determine key learnings \n * H ow can this support the value framework?   \n\n * Determine key deliverabl es and next steps  \n\n  TRIGGER:-P1W END:VALARM END:VEVENT END:VCALENDAR